Real-world tafamidis experience in hereditary transthyretin amyloidosis with peripheral neuropathy in Brazil
Background Tafamidis is a kinetic stabilizer that binds to the transthyretin (TTR) gene, inhibiting its dissociation. It is the only disease-modifying treatment for hereditary TTR amyloidosis with peripheral neuropathy (ATTRv-PN) available in the National Therapeutic Form (Formulário Tera...
Saved in:
Main Authors: | Luiz Felipe Pinto, Marcus V. Pinto, Paula Accioli, Gabriela Amorim, Renata Gervais de Santa Rosa, Moises Dias, Mariana Guedes, Carlos P. Gomez, Roberto C. Pedrosa, Marcia Waddington-Cruz |
---|---|
Format: | Article |
Language: | English |
Published: |
Academia Brasileira de Neurologia (ABNEURO)
2025-01-01
|
Series: | Arquivos de Neuro-Psiquiatria |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1793936 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transthyretin-Related Familial Amyloidosis Polyneuropathy with Spinal Cord Damage: A Case Report
by: Liu H, et al.
Published: (2025-01-01) -
Specific therapeutic options for transthyretin amyloidosis
by: Zoltán Pozsonyi
Published: (2024-12-01) -
Hereditary transthyretin amyloidosis incidentally diagnosed by video-associated lung surgery for lung cancer: A case report
by: Katsuhiro Itogawa, et al.
Published: (2025-01-01) -
Accuracy of Established Prognostic Staging Systems for Cardiac Transthyretin Amyloidosis in the Tafamidis Era
by: Maximilian Leo Müller, MD, et al.
Published: (2025-02-01) -
Clinical features and predictors of atrial fibrillation in patients with light‐chain or transthyretin cardiac amyloidosis
by: Maria Papathanasiou, et al.
Published: (2022-06-01)